Try our Advanced Search for more refined results
Life Sciences - July, 2012
268 articles
- FDA OKs System That Can Sense When Drugs Are Taken
- FDA Announces Biosimilar, Prescription Drug User Fees
- Hikma Beats GSK, Pfizer In Argatroban IP Infringement Row
- Zoll Medical Can't Evade Defibrillator Patent License Suit
- P&G Escapes Claims Of Zinc Poisoning From Denture Cream
- GOP Sens. Question $77M CMS Fraud Prevention Program
- Illumina, Investor Drop Fight Over Poison Pill In Roche Bid
- Grassley Calls For More Probes Of FDA Whistleblower 'Spying'
- Covidien Unit Sues Liberty Mutual For Asbestos Coverage
- Fed. Circ. Blocks Courts From Fixing Overbroad Use Codes
- EU Provides Favorable Turf For Pay-For-Delay Cases
- Apax Sues Endo Over $1.2B Qualitest Deal
- Synthes Sued Over Death Allegedly Tied To Bone Cement Trials
- AstraZeneca Denied Attys' Fees Despite Crestor Patent Win
- Teva Says Genzyme, Ex-Employee Stole Sales Staff
- Genzyme Sues To Stop Generic Leukemia Treatment
- Genzyme Accuses Shire Of Making False Bone Drug Claims
- FDA Releases Medical Device User Fees For 2013
- Doctor Targets Hormone Therapy Co. Over Soured Venture
- Holland & Knight Taps Ex-Kenyon Atty To Lead NY IP Group
- Medicare Denial For Osteoarthritis Device Was OK: 9th Circ.
- Volcano Tentatively Exits Investor Suit Over $27M Payouts
- Q&A With Hodgson Russ' Bethany Trachtenberg
- Classen — A Guide For Post-Prometheus Patent Claims
- Takeaways From Avandia For Medicare Advantage Plans
- Galderma Says Watson Generic Infringes Acne Ointment Patents
- Judge Hands Icahn Ammo In Forest Labs Proxy Battle
- McKesson To Pay $151M To Settle States' Drug Pricing Claims
- Corin, Stryker Bid Adieu To Metal-On-Metal Implant Suit
- Zicam Maker Coughs Up $4.5M to Settle Shareholder Action
- DC Circ. Orders HHS To Justify 12-Year Ban Of Purdue Execs
- FDA Lifts Ban On Dr. Reddy's Drugs From Mexican Plant
- Walgreens, Par Escape Ill. Generic Overcharge Suit
- Ex-Home Diagnostics CEO Says He Didn't Divulge Merger Tips
- Medifast Unit To Fork Over $4M To FTC Over Weight-Loss Ads
- Insurance Exchanges Post-ACA — Questions Remain
- Q&A With Knobbe Martens' Mark Benedict
- Pa. Court Sides With J&J In Risperdal Marketing Suit
- Senate Sends Sequestration Transparency Act To President
- 9th Circ. Opts To Rehear Paraplegic's Medtronic Suit
- GSK's $3B Takeover Of Human Genome Survives 2 Challenges
- FDA Drug Approvals Will Slow In 2012, Report Says
- 8th Circ. Revives Prempro Hormone Suits Against Wyeth
- Terumo Seeks To Beat Sony With $640M Olympus Tie-Up Offer
- RoundTable Rakes In $400M In Aspen Surgical Sale
- Mid Europa Buys 50 Percent Stake In Czech Nutrition Co.
- Nelson V. Matrixx Initiatives — Specificity In Complaints
- 8 Pharma Cos. To Pay $38M For Boosting La. Drug Prices
- US Not Liable For $2M In Ruined HIV Samples: 7th Circ.
- Q&A With Vinson & Elkins' Tracey Davies
- Gray Market Inflating Cost Of Scarce Drugs, Report Says
- University Asks Supreme Court For Rehearing Of ACA Suit
- J&J Unit Says Distributor Tried To Steal 70K Customers
- Bard's Calif. Vaginal Mesh Loss Is No Crystal Ball For MDL
- Docs' Push To Limit Painkiller Prescriptions Faces Long Odds
- Par Pharmaceutical Investor Sues To Halt $1.9B TPG Deal
- Cyberonics' False Claims Cost States $75M: Whistleblower
- Pfizer's Chantix Warning Strong Enough, Judge Says
- CORRECTED: Pfizer Takes Fight Over $142M Neurontin Verdict To 1st Circ.
- Guidant Tells Judge J&J Can't Sue Over Botched $22B Merger
- Human Genome Shareholders Say GSK's $3B Offer Too Low
- EU Finds Lundbeck Pay-For-Delay Deals Blocked Generics
- FDA Says Regulation Doesn't Cause Drug Shortages
- Q&A With Skadden's Jim Elacqua
- Men, Makeup And Drugs
- Calif. County's Drug Disposal Law Headed For Big Pharma Fight
- Travelers Sues Cephalon Over $17M In Actiq Claims
- Almirall, Forest Get EU, FDA Nods For COPD Treatment
- Roche's Accutane Warning Passes Muster In MDL
- Sanofi Warned By FDA Over Conditions In 2 Vaccine Plants
- HHS Skirts Questions On ACA Medicaid Expansion: GOP Govs.
- FDA Staff Backs Broader Use Of Roche Eye Drug
- Blackstone Pours $125M Into NantWorks Biopharmaceutical Arm
- Judge Rules FDA Can Regulate Stem Cell Treatment As Drug
- Novartis Sues Lupin To Protect Diovan Patent
- Q&A With Blake's Jill Lawrie
- 9% Of Employers To Drop Insurance Because Of ACA: Survey
- K-Dur: The Rejection Of 'Scope Of The Patent' Test
- Savient Noteholders Can't Force Receivership, Judge Says
- FDA Must Comply With FOIA Request In Email Spying Suit
- Biovail Puts Up $37.5M To Ditch Wellbutrin Antitrust Case
- J&J Shareholders Sue Over $175M In CEO Compensation
- 9th Circ. Ruling Dooms Pharma Rep OT Suits, Attys Say
- Pharmacies Challenge CMS' Diabetic Supply Payment Change
- Pa. Court Affirms $10M Prempro Judgment Against Pfizer
- Alcon Sues Apotex To Block Vigamox Generic
- FDA Wrongly Approved Generic Vancocin, ViroPharma Argues
- HHS, Pharma Cos. To Offer Streamlined AIDS Patient Assistance
- FDA Says K-V Can't Challenge Its Enforcement Decisions
- Q&A With Choate's Brenda Jarrell
- Fresenius Scoops Up PE-Owned Blood Collection Co.
- Prometheus Unlikely To Sway Fed. Circ.'s Myriad Ruling
- Insurance Co. Says It's Not Liable For Horse Deaths
- Grassley Warns 6 Agencies Of Contractor Data Breach Threat
- Report Faults FDA For Oversight Of Device Cybersecurity
- Q&A With Foley & Lardner's Ybet Villacorta
- Solutia, Pharmacia Take CERCLA Recovery Case To High Court
- UPenn Targets Hospital Over Stalled Immunotherapy Dealings
- Mayo Overlap Between Sections 101 And 102/103 — Not New
- A New View For Pharma Product Liability Litigation
- EU Regulator Backs UniQure's Glybera As First Gene Therapy
- Inventor Kicks Off IP Trial Over Blood Clot Supplement
- Judge Rules Pfizer's Lyrica Patents Are Valid
- Androgel Is FTC's Best Shot At High Court Pay-For-Delay Case
- Drugmaker Taro Rejects Sun Pharma's Latest Buyout Bid
- Judge Won't Cut Weisheng Parent From Vitamin C Cartel Case
- Obesity Drug Approvals Foretell A Less Cautious FDA
- Anti-Painkiller Abuse Bill Might Inflate Cost Of Generics
- EU Court OKs Extended Patents For New Uses Of Old Drugs
- Reps. Seek 'Patient' Clarity In Low-Cost Drug Program
- Bayer Beats Baycol FCA Suit
- Snapshot: The Latest Medical Device FCPA Settlement
- Pharmacy Group Recommends Narrow ACA Drug Coverage
- Q&A With McAndrews' Herb Hart
- Travelers Sues Pfizer For $47M Over Epilepsy Drug
- Biosimilars Makers See Gold Mine In EU Clinical Data
- Genzyme Hit With $50M Judgment In Fabry Treatment IP Fight
- Cephalon Defends Narcolepsy Drug From Generics At Trial
- 11th Circ. Won't Rehear FTC Androgel Pay-For-Delay Case
- Novartis Picks Up Win In Okla. Bone Drug Injury Suit
- FDA Again Delays Nod For Novo Nordisk Long-Acting Insulin
- Somaxon Settles IP Rows With Mylan, Par Over Insomnia Drug
- Q&A With Vinson & Elkins' Ira Schreger
- Abbott Fairly Kept Gay Man Out Of GSK Jury, 9th Circ. Hears
- Reach Of Prometheus Will Come Into Focus In Myriad Ruling
- House Votes To Force OMB To Reveal Sequestration Plans
- Examining Sequenom Prenatal Testing Patent Litigation
- Preempting State Law To Protect Patient Privilege
- FDA OKs Vivus Weight Drug Qsymia After Nod To Rival Arena
- Vt. Owes $2.2M To Health Data Cos. Over Supreme Court Case
- Jones Day Reps Steris In $270M US Endoscopy Buy
- GOP Rep. Wants To Open CBO Numbers To More Scrutiny
- Biosimilars Industry Hopes For Jump-Start From User Fees
- Google Board Sued By Pension Fund Over Online Drug Sales
- Hospira Yanks Cancer Drugs After Finding Flawed Vials
- Shionogi Sues To Block Another Generic Fortamet Challenge
- Q&A With Hogan Lovells' Meredith Manning
- FDA Lawyers Gave Email 'Spying' Green Light, Reports Say
- Device Makers, Doctors Spar Over X-Ray Safety For Kids
- EU Plan To Release More Drug Data Could Spur More US Suits
- SEC Can't Use SOX To Claw Back Bonuses: ArthroCare Execs
- 3rd Circ. Pay-For-Delay Ruling Opens Door To High Court
- FTC OKs Novartis' $1.5B Fougera Buy With Divestitures
- FCA Recoveries On Steep Rise To Record Highs, Report Says
- FDA Approves Gilead Drug To Prevent HIV
- Watson To Pay $1.7M To Exit Idaho AG's Drug Pricing Suit
- Panasonic Accuses CardioNexus Of Obscuring Software's Value
- J&J Beats MDL Over Defective Children's Drugs
- Daiichi Sankyo Sales Reps Drop OT Suit Citing GSK Ruling
- Ex-Sanofi Exec Named Head Of FDA Generics Office
- WilmerHale Reps Thermo Fisher In $925M Buy Of One Lambda
- J&J Heir's $140M Tax Advice Suit Too Late, Proskauer Says
- GSK Finally Lands Human Genome With Upped $3B Offer
- Q&A With Sullivan & Cromwell's Matthew Hurd
- FCA's First-To-File Rule — Mass. Weighs In
- TPG Offers $1.9B For Generic Drug Co. Par Pharmaceutical
- Cephalon Sues To Block Travelers' $17M Actiq Coverage Claim
- Livestock Antibiotic Rules Too Lax, Health Groups Say
- Ala. Court Nixes $78M Price Inflation Verdict Against Sandoz
- Boston Scientific, St. Jude End Data Poaching Dispute
- Sanofi, FedEx Hit Roadblock On Spoiled-Vaccine Settlement
- Q&A With Bingham's Jack Concannon
- Novartis Cancer Unit Escapes Securities Suit
- Lab Won't Explain $82M IP Damages: Ex-Ropes & Gray Atty
- Global Drug Spending To Climb Amid Market Shifts, Report Says
- FDA Aims To Boost Device Makers' Faith In Early Meetings
- CVS Caremark To Halt Coverage For 17 Drugs
- FDA Plans Genome Database For Deadly Foodborne Bacteria
- Bayer Should Ax Calcium Supplement Claims: Ad Regulator
- GSK Tells 3rd Circ. Avandia MDL Cases Can't Be Appealed
- 1st Circ. Kills Investor Suit Over Boston Scientific Sales
- Fed. Circ. Trims Investigation Rules In Vaccine Suits
- GSK Yanks Bid To Combine Tykerb With Roche's Herceptin
- GSK Settlement: Changing The Way Drug Cos. Do Business?
- Q&A With Axinn's Chad Landmon
- FTC Seeks More Info On $5.2B Watson, Actavis Merger
- J&J Vows To Fix Compliance, Quality Issues In Investor Deal
- House Passes 2nd Bill To Repeal Health Care Law
- DOJ Develops A Taste For Deferred Prosecution Deals
- Brain Research Labs Cuts Deal In Class Suit Over Memory Pill
- Hemispherx Says FDA Will Accept Ampligen Analyses
- King & Spalding Hires Ex-Amgen Exec For FDA Practice
- AstraZeneca Wins Seroquel Suit, But Court Punts Warning Issue
- GE Healthcare Recalls Ventilators Over Anesthesia Risks
- How A Texas Plaintiff Found A Way To Causation
- Q&A With Skadden's Douglas Nemec
- UK Court Finds Teva's Copaxone Patent Valid In Mylan Row
- Awaiting The High Court Amgen Decision
- Time Will Tell If FDA Review Update Quickens Drug Approval
- Stryker Recall Undercuts Key Defense For Implant Makers
- Barr Seeks To Use Mensing As Shield In Accutane MDL
- FTC Won't Abandon Pay-For-Delay Offensive, Chief Says
- Masimo Must Face FCA Claims That It Peddled Shoddy Devices
- How They Won It: Lowenstein Breaks Ground With Schering Win
- Orthofix Pays $7.5M To Settle Bribery Cases With SEC, DOJ
- Cubist Hits Hospira With Patent Suit Over Generic Cubicin
- Pharma Co. Shionogi Sues InterMune Over Drug Royalties
- Understanding Mayo V. Prometheus
- Q&A With Knobbe Martens' Joseph Reisman
- Obama Signs FDA User Fee Bill
- Animal Agriculture Groups Blast Report On Antibiotic Use
- FDA Cleared Of Wrongdoing In Generic Xibrom Suit
- FDA Orders Opioid Makers To Fund Abuse Prevention Training
- Dendreon Execs Sued Over Sunny Cancer Drug Sales Forecasts
- HHS OIG Finds Nursing Homes Not Complying With Medicare Regs
- Mass. Loosens Ban On Medical Device Co. Gifts To Doctors
- Employers Will Rush To Comply With ACA Ruling, Report Says
- Mylan Accuses Warner, Mayne Of Plot To Delay Generics
- Hedge Fund Manager Attacked Over Biotech Stock Short Sales
- ACA Loss Ratio Rules Hurt Anti-Fraud Effort, Insurers Say
- Monsanto, Pfizer Try To Revive Enviro Feud With Trucking Co.
- FDA Recalls Maquet Anesthesia Devices Over Ventilation Risk
- Q&A With Quinn Emanuel's Victoria Maroulis
- Legal Challenges, Risks Of Rx Drug Adherence Programs
- Whole Foods Supplements Contain Lead, False Ads Suit Says
- Calif. Judge Won't Halt Sale Of Prenatal Blood Test In IP Row
- Novartis, Merck Hit With RICO Suits Over Drug Copays
- Pfizer To Remove Centrum Breast, Colon Health Claims
- Roche's Breast Cancer Drug Doesn't Make UK Watchdog's Cut
- Allergan Defeats Calif. Doctor's $4M Fraud Suit
- 1st Circ. Stays $26M Drug Injury Award For Mutual's Appeal
- Walgreens, Kroger Sue Pfizer For Delay Of Generic Lipitor
- Endo Targets Generics Makers Over Lidoderm Patch IP
- AstraZeneca Loses Bid To Stretch Seroquel Exclusivity
- Q&A With Baker Botts' Earl Austin
- 4 Drug Cos. Can't Exit FCA Suit Over Medicaid Rebate Prices
- FDA Moves To Crack Down On Unapproved Oxycodone
- Calif. Assembly Advances 2 Health Bills Expanding On ACA
- Sen. Pushes Labeling Rule To Curb Infant Drug Withdrawal
- USPTO Memo Tells Examiners How To Apply Prometheus
- FDA Proposes New Premarket Approval For Some SWD Devices
- Medicare Competitive Bidding Needs Makeover, Study Says
- K-V Pharma Sues FDA Over Exclusivity For Preterm Birth Drug
- Roche Gains FDA Approval For Cytomegalovirus Test
- K&L Gates Hires Nutrition Law Partner For Brussels Office
- Obama Says Health Care Law Is 'Here To Stay'
- Sales Reps Slap Forest Labs With $100M Sex Bias Case
- Pacemaker Electrodes To Switch Approval Processes At FDA
- Robins Kaplan Adds Wilson Sonsini Drug Patent Atty In NY
- Aussie Drug Cos. Will Have To Reveal Doctor Payments
- Jones Day Aids Bayer CropScience In $425M AgraQuest Buy
- A New Prosecutorial Model For Health Care Fraud
- Q&A With Epstein's Kathleen Peterson
- Covance Says It Doesn't Owe $22M In Software License Fees
- Medicare Likely Pays Twice for Hospice Drugs, Audit Says
- House Panel Sees Tax Implications In High Court ACA Ruling
- FDA Unveils Long-Delayed Device Tracking Rule Proposal
- Amylin Shareholder Sues Over $7B Sale To Bristol-Myers
- FDA May Amend Liver Damage Warnings For Acetaminophen
- Roche Must Cough Up $1M Over Scientist Firing, NJ Court Says
- FDA Outlines Approval Process For Medical Detection Systems
- Q&A With Sheppard Mullin's Blaine Templeman
- Sales Reps Say GSK Ruling Doesn't Bar State OT Claims
- Omnicare Asks For Protection From Expected FCA Suit Flood
- How To Use Clinical-Trial Data In Court
- DaVita Inks $55 Million Settlement In Epogen FCA Suit
- Fed. Circ. Nixes Injunction On Lupin's Generic Fortamet
- McKesson Can't Duck Generic Darvocet Liability Claims
- Abbott Again Goes After Sandoz Over Generic Zemplar
- Mylan, Lupin Prevail In Generic-Seasonique Patent Suit
- PolyMedix Hid Drug's Flaws Before $20M Stock Deal, Suit Says
- Hospira Defeats Class Action Over Drug Shortage
- Bristol-Myers, AstraZeneca Team Up On $7B Amylin Deal
- Glaxo Handing Over Record $3B To Settle FCA Claims
- Coca-Cola, GSK, Sherwin-Williams Face CERCLA Suit
- Q&A With Quinn Emanuel's Peter Armenio
- An Overview Of Congress' Sweeping FDA Reforms
- Dewey & LeBoeuf And The 'Unfinished Business' Doctrine